Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Eur J Appl Physiol. 2019 Sep 13;119(11-12):2457–2464. doi: 10.1007/s00421-019-04227-1

Table 1:

Descriptives (n = 29)

Variables Overall
Age (yrs) 55 ± 7
Race
 European American 18 (62%)
 African American 11 (38%)
Height (m) 1.61 ± 0.06
Body Mass (kg) 83.6 ± 24.2
Fat mass (kg) 40.6 ± 17.4
Fat-free mass (kg) 43.1 ± 7.8
Body mass index (kg/m2) 32.2 ± 9.1
Waist circumference (cm) 90 ± 20
Hip circumference (cm) 115 ± 18
Waist-to-hip ratio 0.80 ± 0.06
Peak V˙O2 (mL·kg−1·min−1) 20.5 ± 4.8
Barriers Self-Efficacy (au)^ 47.3 ± 24.1
Employed (yes) [no. (%)] 16 (55%)
Marital status [no. (%)]
 Married or living with sig other 17 (59%)
 Other 12 (41%)
Cancer stage [no. (%)]
 DCIS 2 (7%)
 1 9 (31%)
 2 14 (48%)
 3 4 (14%)
Months since breast cancer diagnosis 53 ± 61
History of chemotherapy (yes) [no. (%)] 19 (66%)
History of radiation (yes) [no. (%)] 17 (59%)
Current hormonal therapy
 Aromatase inhibitor (yes) 9 (31%)
 Estrogen receptor modulator (yes) 4 (14%)
Menopause [no. (%)]
 Pre-menopausal 4 (14%)
 Unsure 2 (7%)
 Post-menopausal 23 (79%)
Current smoker (yes) [no. (%)] 2 (6%)
Alcohol (yes) [no. (%)] 11 (38%)

Values are shown as means and standard deviations unless noted otherwise. Fat mass and fat-free mass were determined by deuterium dilution. Peak V˙O2, peak oxygen uptake; DCIS, ductal carcinoma in situ.

^

Evaluated using a 9-item questionnaire.